Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Revolutionizing Stem Cell Sorting with Machine Learning: A Review of Trends, Tools, and Future Directions.

Iranian journal of medical sciences·2026

Same author

Levels of bone formation marker P1NP in individuals over 50 years: a systematic review and meta-analysis.

Journal of diabetes and metabolic disorders·2026

Same author

Measuring the Acceptance of Humanoid Robots in Adult Day Care Facilities.

Studies in health technology and informatics·2026

Same author

Impact of metformin on bone turnover markers: a systematic review and meta-analysis of clinical trials.

Archives of osteoporosis·2026

Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Search research articles

Related Experiment Video

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

Technology and Dementia Preconference.

Arshia A Khan¹, Patricia Khashayar²

¹University of Minnesota Duluth, Duluth, MN, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association

|December 23, 2025

Summary

This summary is machine-generated.

Robotic-assisted physical therapy shows promise for dementia patients, improving engagement and cognitive function. This non-pharmacological approach enhances quality of life in memory care settings.

More Related Videos

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Related Experiment Videos

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Area of Science:

Gerontology
Rehabilitation Medicine
Neuroscience

Background:

Dementia impacts over 55 million globally, causing declines in mobility and cognition.
Apathy limits engagement in traditional physical therapy for dementia patients.
Robotic-assisted therapy offers an interactive rehabilitation alternative.

Purpose of the Study:

To investigate the impact of robotic-assisted therapy on mobility, cognition, and emotional well-being in memory care residents.
To assess the feasibility and effectiveness of a robotic system in guiding physical therapy exercises.

Main Methods:

A seven-week intervention involving seven memory care residents using a robotic system for guided physical therapy.
Electrodermal activity (EDA) measured physiological responses and engagement levels.
Cognitive and functional changes assessed using the Brief Interview for Mental Status (BIMS) survey.

Main Results:

Therapy sessions significantly increased EDA tonic mean and standard deviation, indicating heightened physiological arousal and engagement.
Participants showed increased responsiveness during robotic-assisted exercises.
Improvements in BIMS scores suggest cognitive benefits.

Conclusions:

Robotic-assisted therapy is a promising non-pharmacological intervention for dementia care.
It enhances engagement, mobility, cognition, and emotional well-being.
Robotic rehabilitation complements traditional therapy, improving quality of life.